JENNIFER SCHNIPPERT: Open Payments
NPI 1801204987 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 21 payments from 16 companies in 2025. Trend: 2023 $532 · 2024 $906 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $123 |
| MDD US Operations, LLC | 1 | $118 |
| AstraZeneca Pharmaceuticals LP | 1 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Abbott Laboratories | 3 | $112 |
| Lilly USA, LLC | 2 | $108 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| ABBVIE INC. | 1 | $90 |
| Dexcom, Inc. | 2 | $62 |
| Exact Sciences Corporation | 2 | $40 |
Products named: Leqembi, BREZTRI, AUSTEDO XR, FREESTYLE LIBRE 3, REXULTI, LINZESS, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
